VBI

VBI Vaccines is a Massachusetts-based biopharmaceutical company that researches and develops novel vaccines for the treatment of cancer and infectious diseases.

Business Model:

Revenue: $396k

Employees: 11-50

Detailed VBI Information

Geographic Data

VBI headquarters map

Address: 160 Second Street

City: Cambridge

State: MA

Zip: 02142

Country: US

Financial Info

Stage:

post ipo debt

Raised Last:

$12M

Raised Total:

$381M

Metrics

2,310,119Website Global Rank

8,145Website Monthly Traffic

Twitter Followers

Description

VBI Vaccines is a Massachusetts-based biopharmaceutical company that researches and develops novel vaccines for the treatment of cancer and infectious diseases.

Contact Phone:
+16178303031

Contact Email:

VBI went public on 2/24/2012 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
2/24/2012

Ticker Symbol:
VBIV

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
3/2013 Post-IPO Debt $751.1k
9/2019 Post-IPO Equity $40.3M
10/2017 Post-IPO Equity 1 $71.9M Pontifax
Pontifax
5/2021 Post-IPO Debt 1 $12M K2 HealthVentures
K2 HealthVentures
9/2022 Post-IPO Debt $100M K2 HealthVentures
4/2020 Post-IPO Equity $1.1M
12/2018 Post-IPO Equity $37.5M
12/2013 Post-IPO Debt $1.4M
12/2016 Post-IPO Equity 1 $10.6M Perceptive Advisors
Perceptive Advisors
Perceptive Advisors
Perceptive Advisors
6/2013 Post-IPO Debt $750k
3/2014 Post-IPO Debt $1.5M
1/2007 Series A 3 $35.7M Clarus Ventures
ARCH Venture Partners
5AM Ventures
Clarus Ventures
ARCH Venture Partners
5AM Ventures
7/2011 Debt Financing $3.5M
12/2018 Post-IPO Equity $42.9M
12/2016 Post-IPO Debt 1 $13M Perceptive Advisors
Perceptive Advisors
Perceptive Advisors
Perceptive Advisors
2/2012 Debt Financing $2.2M
11/2010 Debt Financing $4.3M
7/2016 Post-IPO Equity $0 OPKO Health
Perceptive Advisors
ARCH Venture Partners
OPKO Health
OPKO Health
Perceptive Advisors
ARCH Venture Partners
OPKO Health
8/2014 Post-IPO Equity $11M
9/2022 Post-IPO Debt 1 $100M K2 HealthVentures
K2 HealthVentures
7/2012 Post-IPO Debt $1.2M
8/2013 Post-IPO Debt $250k
8/2015 Post-IPO Equity $6.3M
4/2020 Post-IPO Equity $57.5M
5/2020 Post-IPO Debt 1 $50M K2 HealthVentures
K2 HealthVentures
K2 HealthVentures
K2 HealthVentures
7/2016 Post-IPO Equity 3 $13.6M OPKO Health
Perceptive Advisors
ARCH Venture Partners
OPKO Health
OPKO Health
Perceptive Advisors
ARCH Venture Partners
OPKO Health
Announced Date Name Price
5/2016 SciVac Therapeutics
9/2011 Epixis

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research